Back
Edgewise Therapeutics, Inc. Vs. Apogee Enterprises, Inc. Industry Stock Comparison
Buy
51
EWTX
Edgewise Therapeutics, Inc.
Last Price:
$24.59
Seasonality Move:
-17.98%
Sell
40
APOG
Apogee Enterprises, Inc.
Last Price:
$34.81
Seasonality Move:
5.5%
Buy
51
Edgewise Therapeutics, Inc. (EWTX)
is a Buy
Is Edgewise Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Edgewise Therapeutics, Inc. [EWTX] share price is $24.97. The Score for EWTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Apogee Enterprises, Inc. (APOG)
is a Sell
Is Apogee Enterprises, Inc. a Buy, Sell or Hold?
-
The current Apogee Enterprises, Inc. [APOG] share price is $33.77. The Score for APOG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics, Inc.'s stock price today?
-
The Edgewise Therapeutics, Inc. share price today is $24.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises, Inc.'s stock price today?
-
The Apogee Enterprises, Inc. share price today is $33.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing slight buying pressure.
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 55.01 | Buy |
| Chaikin Money Flow: | 577207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.31 - 25.17) | Buy |
| Bollinger Bands (100): | (14.35 - 22.69) | Buy |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 35.89 | Sell |
| Chaikin Money Flow: | 244445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.92 - 39.76) | Sell |
| Bollinger Bands (100): | (35.93 - 43.19) | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.56 | Buy |
| 20-day SMA: | 23.82 | Buy |
| 50-day SMA: | 22.13 | Buy |
| 200-day SMA: | 16.6 | Buy |
| 8-day EMA: | 24.32 | Buy |
| 20-day EMA: | 23.87 | Buy |
| 50-day EMA: | 22.08 | Buy |
| 200-day EMA: | 19.14 | Buy |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.04 | Sell |
| 20-day SMA: | 37.95 | Sell |
| 50-day SMA: | 36.64 | Sell |
| 200-day SMA: | 40.8 | Sell |
| 8-day EMA: | 35.7 | Sell |
| 20-day EMA: | 36.87 | Sell |
| 50-day EMA: | 37.57 | Sell |
| 200-day EMA: | 42.57 | Sell |
Edgewise Therapeutics, Inc. Earnings Growth & EWTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.14 per share.
Apogee Enterprises, Inc. Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.42 per share, and a decrease next year of $0.04 per share.
Edgewise Therapeutics, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||